Tocilizumab for severe COVID-19: a systematic review and meta-analysis.

Int J Antimicrob Agents · 2020 · PMC7377685 · PMID 32712333

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the difference did not reach statistical significance [risk ratio (RR) = 0.62, 95% confidence interval (CI) 0.31–1.22; I 2 = 68%].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.